Skip to main content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2006 | OriginalPaper | Hoofdstuk

Is een mammografie aan te raden voor aanvang van hormonale substitutietherapie?

Auteur : Dr. H.A.I.M. van Leusden

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Men moet zich realiseren dat de incidentie van het mammacarcinoom bij niet-toepassing van hormonale substitutietherapie hoog is.
Literatuur
go back to reference Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-37. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-37.
go back to reference Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 1896; 2: 104-7. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 1896; 2: 104-7.
go back to reference Jensen EV, Block GE, Smith S, et al. Estrogen receptors and breast cancer response to adrenalectomy. In: Prediction of response in Cancer Therapy. National Institutes of Health, Education and Welfare, 1971: 55-70. Jensen EV, Block GE, Smith S, et al. Estrogen receptors and breast cancer response to adrenalectomy. In: Prediction of response in Cancer Therapy. National Institutes of Health, Education and Welfare, 1971: 55-70.
go back to reference Toniolo P, Levitz M, Zeleniuch-Jacquotte, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87: 190-97. Toniolo P, Levitz M, Zeleniuch-Jacquotte, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87: 190-97.
go back to reference Smith PG, Doll R. Late effects of X-radiation in patients treated for metropathia haemorrhagica. Br J Radiol 1976; 49: 224-32. Smith PG, Doll R. Late effects of X-radiation in patients treated for metropathia haemorrhagica. Br J Radiol 1976; 49: 224-32.
go back to reference Colditz GA, Hankinson SE, Hunter DJ et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-93. Colditz GA, Hankinson SE, Hunter DJ et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-93.
go back to reference Persson I. Cancer risk in women receiving estrogen-progestin replacement therapy. Maturitas 1996; Suppl 23: S37 – S45. Persson I. Cancer risk in women receiving estrogen-progestin replacement therapy. Maturitas 1996; Suppl 23: S37 – S45.
go back to reference Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J Am Med Assoc 1995; 274: 137-42. Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J Am Med Assoc 1995; 274: 137-42.
go back to reference Theriault RL. Hormone replacement therapy and breast cancer: an overview. Br J Obstet Gynaecol 193; supplement 13: 87-91. Theriault RL. Hormone replacement therapy and breast cancer: an overview. Br J Obstet Gynaecol 193; supplement 13: 87-91.
go back to reference Burger CW, Koomen I, Peters NJAB, Leeuwen FE van, Kenemans P. Postmenopausal hormone replacement therapy and cancer of the female genital tract and the breast. Eur Menopause J 1997; 4: 23-36. Burger CW, Koomen I, Peters NJAB, Leeuwen FE van, Kenemans P. Postmenopausal hormone replacement therapy and cancer of the female genital tract and the breast. Eur Menopause J 1997; 4: 23-36.
go back to reference Burger CW, Koomen I, Peters NJAB, Leeuwen FE van, Kenemans P. Postmenopauzale hormonale suppletietherapie en kanker van de vrouwelijke geslachtsorganen en de mamma. Ned Tijdschr Geneeskd 1997; 141: 368-72. Burger CW, Koomen I, Peters NJAB, Leeuwen FE van, Kenemans P. Postmenopauzale hormonale suppletietherapie en kanker van de vrouwelijke geslachtsorganen en de mamma. Ned Tijdschr Geneeskd 1997; 141: 368-72.
go back to reference Bergkvist L, Persson I, Adami HO, Schairer C. Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogens. Int J Epidemiol 1988; 17: 732-37. Bergkvist L, Persson I, Adami HO, Schairer C. Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogens. Int J Epidemiol 1988; 17: 732-37.
go back to reference Velde ER te, Leusden HAIM van. Hormonal treatment for the climacteric: alleviation of symptoms and prevention of postmenopausal disease. Lancet 1994; 343; 654-58. Velde ER te, Leusden HAIM van. Hormonal treatment for the climacteric: alleviation of symptoms and prevention of postmenopausal disease. Lancet 1994; 343; 654-58.
go back to reference Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29-43. Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29-43.
go back to reference Chang K-J, Lee TTY, Linares-Cruz GL, et al. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertility and Sterility 1995; 63: 785-91. Chang K-J, Lee TTY, Linares-Cruz GL, et al. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertility and Sterility 1995; 63: 785-91.
go back to reference Nortier JWR, Kluck HM, Sybrandy R, Beex LVAM. Mammacarcinoom; adviezen ten aanzien van nacontrole, hormonale anticonceptie of substitutie met oestrogenen en zwangerschap. Ned Tijdschr Geneeskd 1990; 134: 1934-37. Nortier JWR, Kluck HM, Sybrandy R, Beex LVAM. Mammacarcinoom; adviezen ten aanzien van nacontrole, hormonale anticonceptie of substitutie met oestrogenen en zwangerschap. Ned Tijdschr Geneeskd 1990; 134: 1934-37.
go back to reference American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992; 117: 1038-41. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992; 117: 1038-41.
go back to reference Barentsen R, Weijer PHM van de. Suppletie van hormonen in het climacterium en de postmenopauze anno 1996. Uitgave Ciba, Arnhem. ISBN 90-6609043X. Barentsen R, Weijer PHM van de. Suppletie van hormonen in het climacterium en de postmenopauze anno 1996. Uitgave Ciba, Arnhem. ISBN 90-6609043X.
go back to reference Kenemans P, Barentsen R, Weijer PHM van de (eds). Practical HRT, 2nd edition. Zeist: Medical Forum International, 1996. ISBN 90-56980084. Kenemans P, Barentsen R, Weijer PHM van de (eds). Practical HRT, 2nd edition. Zeist: Medical Forum International, 1996. ISBN 90-56980084.
go back to reference Dam PA van, Waes A van, Tjalma W, Buytaert P. HST en borstkanker. Tijdschr Clim Postm; 11: 13-14. Dam PA van, Waes A van, Tjalma W, Buytaert P. HST en borstkanker. Tijdschr Clim Postm; 11: 13-14.
Metagegevens
Titel
Is een mammografie aan te raden voor aanvang van hormonale substitutietherapie?
Auteur
Dr. H.A.I.M. van Leusden
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_718